These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23786357)

  • 1. Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: antimicrobial activity, in vitro inhibition of translation, and drug resistance.
    Berkov-Zrihen Y; Green KD; Labby KJ; Feldman M; Garneau-Tsodikova S; Fridman M
    J Med Chem; 2013 Jul; 56(13):5613-25. PubMed ID: 23786357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putting the antibiotics chloramphenicol and linezolid into context.
    Crowe-McAuliffe C; Wilson DN
    Nat Struct Mol Biol; 2022 Feb; 29(2):79-81. PubMed ID: 35165457
    [No Abstract]   [Full Text] [Related]  

  • 3. Derivatives of Ribosome-Inhibiting Antibiotic Chloramphenicol Inhibit the Biosynthesis of Bacterial Cell Wall.
    Louzoun Zada S; Green KD; Shrestha SK; Herzog IM; Garneau-Tsodikova S; Fridman M
    ACS Infect Dis; 2018 Jul; 4(7):1121-1129. PubMed ID: 29714997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction.
    Protein Sci; 2020 Mar; 29(3):623-628. PubMed ID: 32058636
    [No Abstract]   [Full Text] [Related]  

  • 5. Ribosome-targeting antibiotics and mechanisms of bacterial resistance.
    Wilson DN
    Nat Rev Microbiol; 2014 Jan; 12(1):35-48. PubMed ID: 24336183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development.
    Arenz S; Wilson DN
    Mol Cell; 2016 Jan; 61(1):3-14. PubMed ID: 26585390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin Variants with Enhanced Ribosome-Targeting Activity.
    Fosso MY; Zhu H; Green KD; Garneau-Tsodikova S; Fredrick K
    Chembiochem; 2015 Jul; 16(11):1565-70. PubMed ID: 26033429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lincomycin, clindamycin and their applications.
    Spízek J; Rezanka T
    Appl Microbiol Biotechnol; 2004 May; 64(4):455-64. PubMed ID: 14762701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient discovery of novel antimicrobials through integration of synthesis and testing in crude ribosome extract.
    Sang Z; Lu Y; Zhou Y; Ju Y; An Q; Shen S; Shi J; He J; Yang T; Luo Y
    Chem Commun (Camb); 2019 May; 55(42):5886-5889. PubMed ID: 31041938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the Nucleoside Antibiotics as Universal Translation Inhibitors.
    Nelli MR; Heitmeier KN; Looper RE
    Acc Chem Res; 2021 Jul; 54(13):2798-2811. PubMed ID: 34152729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modular Chemical Synthesis of Streptogramin and Lankacidin Antibiotics.
    Cai L; Seiple IB; Li Q
    Acc Chem Res; 2021 Apr; 54(8):1891-1908. PubMed ID: 33792282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalently linked kanamycin - Ciprofloxacin hybrid antibiotics as a tool to fight bacterial resistance.
    Shavit M; Pokrovskaya V; Belakhov V; Baasov T
    Bioorg Med Chem; 2017 Jun; 25(11):2917-2925. PubMed ID: 28343755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic antibiotic class overcoming bacterial multidrug resistance.
    Mitcheltree MJ; Pisipati A; Syroegin EA; Silvestre KJ; Klepacki D; Mason JD; Terwilliger DW; Testolin G; Pote AR; Wu KJY; Ladley RP; Chatman K; Mankin AS; Polikanov YS; Myers AG
    Nature; 2021 Nov; 599(7885):507-512. PubMed ID: 34707295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual effect of chloramphenicol peptides on ribosome inhibition.
    Bougas A; Vlachogiannis IA; Gatos D; Arenz S; Dinos GP
    Amino Acids; 2017 May; 49(5):995-1004. PubMed ID: 28283906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.
    Ebbensgaard A; Mordhorst H; Overgaard MT; Nielsen CG; Aarestrup FM; Hansen EB
    PLoS One; 2015; 10(12):e0144611. PubMed ID: 26656394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Numbers Game: Ribosome Densities, Bacterial Growth, and Antibiotic-Mediated Stasis and Death.
    Levin BR; McCall IC; Perrot V; Weiss H; Ovesepian A; Baquero F
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing translation with small-molecule inhibitors.
    Blanchard SC; Cooperman BS; Wilson DN
    Chem Biol; 2010 Jun; 17(6):633-45. PubMed ID: 20609413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design.
    Lin J; Zhou D; Steitz TA; Polikanov YS; Gagnon MG
    Annu Rev Biochem; 2018 Jun; 87():451-478. PubMed ID: 29570352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of agents targeting the bacterial ribosome.
    Bower J; Drysdale M; Hebdon R; Jordan A; Lentzen G; Matassova N; Murchie A; Powles J; Roughley S
    Bioorg Med Chem Lett; 2003 Aug; 13(15):2455-8. PubMed ID: 12852942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using the Bacterial Ribosome as a Discovery Platform for Peptide-Based Antibiotics.
    Charon J; Manteca A; Innis CA
    Biochemistry; 2019 Jan; 58(2):75-84. PubMed ID: 30372045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.